12/18/2012 9:00:09 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that Kenneth DiPietro, Executive Vice President Human Resources at Biogen Idec, has joined InVivo’s Board of Directors. DiPietro has also been appointed as Chair of the Board’s Governance, Nominating and Compensation committee. InVivo has pioneered a new technology platform utilizing a variety of biocompatible polymer-based devices to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving functional recovery and prognosis after a traumatic spinal cord injury. Today there is no effective treatment for traumatic spinal cord injuries, and the market potential is estimated to exceed $10 billion. Mr. DiPietro brings 30 years of experience in the human resources field to InVivo’s Board. As a senior executive and respected global business leader, Mr. DiPietro is accomplished at linking human resources functional excellence to the achievement of corporate objectives. He has gained broad cultural transformation, organizational development and corporate re-engineering experience with several Global 500 companies including Biogen, Microsoft, and PepsiCo, Inc.
comments powered by